5 Key Takeaways

• 1

  Alterations in the gut microbiome and intestinal barrier are linked to more severe outcomes in metabolic dysfunction–associated steatotic liver disease (MASLD).

• 2

  MASLD is the most common chronic liver disease globally and increases susceptibility to infections like Vibrio vulnificus.

• 3

  Mice with MASLD exhibited more severe liver injury, higher liver enzyme levels, and increased inflammation after Vibrio vulnificus infection.

• 4

  Disruption of intestinal barrier function in MASLD mice was evidenced by reduced tight junction proteins and increased gut permeability markers.

• 5

  Fecal microbiota transplantation from healthy donors improved liver injury and inflammation in MASLD mice, suggesting microbiome's role in disease severity.